Nishank Bhalla | Senior Scientist
Advanced Virology, Inc.

Dr. Nishank Bhalla, CEO of Advanced Virology, is an experienced molecular virologist with extensive experience in the creation and use of reverse genetics systems for virus stock production. He previously worked as a scientist at the American Type Culture Collection (ATCC). While at ATCC, he performed large-scale production and purification of viruses in an industrial setting. These productions included quality control and quality assurance assays such as TCID50, IFA, HA titer, sterility and contamination tests, and genomic sequencing. He co-founded Advanced Virology Inc. in 2022 along with four other collaborators to commercialize reverse genetics-based virus stock production methods. His work at Advanced Virology involves managing the day-t-day operations of the company, building the company’s catalog of virus stocks and fulfillment of custom virus orders from clients in academia and industry.